EP2190455A4 - AGENTS HAVING ANGIOGENIC AND WOUND HEALING ACTIVITY - Google Patents

AGENTS HAVING ANGIOGENIC AND WOUND HEALING ACTIVITY

Info

Publication number
EP2190455A4
EP2190455A4 EP08783056A EP08783056A EP2190455A4 EP 2190455 A4 EP2190455 A4 EP 2190455A4 EP 08783056 A EP08783056 A EP 08783056A EP 08783056 A EP08783056 A EP 08783056A EP 2190455 A4 EP2190455 A4 EP 2190455A4
Authority
EP
European Patent Office
Prior art keywords
angiogenic
medium
wound healing
healing activity
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08783056A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2190455A1 (en
Inventor
Keryn Johnson
Madhusudan Vasudevamurthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meat and Livestock Autralia Ltd
Australian Meat and Live Stock Research and Development Corp
Callaghan Innovation Research Ltd
Original Assignee
Meat and Livestock Autralia Ltd
Australian Meat and Live Stock Research and Development Corp
Industrial Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007904857A external-priority patent/AU2007904857A0/en
Application filed by Meat and Livestock Autralia Ltd, Australian Meat and Live Stock Research and Development Corp, Industrial Research Ltd filed Critical Meat and Livestock Autralia Ltd
Priority to EP11164650A priority Critical patent/EP2407175A1/en
Publication of EP2190455A1 publication Critical patent/EP2190455A1/en
Publication of EP2190455A4 publication Critical patent/EP2190455A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
EP08783056A 2007-09-07 2008-09-05 AGENTS HAVING ANGIOGENIC AND WOUND HEALING ACTIVITY Withdrawn EP2190455A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP11164650A EP2407175A1 (en) 2007-09-07 2008-09-05 Agents with angiogenic and wound healing activity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2007904857A AU2007904857A0 (en) 2007-09-07 Agents with angiogenic and wound healing activity
PCT/AU2008/001319 WO2009029991A1 (en) 2007-09-07 2008-09-05 Agents with angiogenic and wound healing activity

Publications (2)

Publication Number Publication Date
EP2190455A1 EP2190455A1 (en) 2010-06-02
EP2190455A4 true EP2190455A4 (en) 2010-11-24

Family

ID=40428369

Family Applications (2)

Application Number Title Priority Date Filing Date
EP08783056A Withdrawn EP2190455A4 (en) 2007-09-07 2008-09-05 AGENTS HAVING ANGIOGENIC AND WOUND HEALING ACTIVITY
EP11164650A Ceased EP2407175A1 (en) 2007-09-07 2008-09-05 Agents with angiogenic and wound healing activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP11164650A Ceased EP2407175A1 (en) 2007-09-07 2008-09-05 Agents with angiogenic and wound healing activity

Country Status (6)

Country Link
US (1) US8404644B2 (enExample)
EP (2) EP2190455A4 (enExample)
JP (1) JP5685773B2 (enExample)
AU (1) AU2008295449A1 (enExample)
NZ (1) NZ583803A (enExample)
WO (1) WO2009029991A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009029991A1 (en) * 2007-09-07 2009-03-12 Meat & Livestock Australia Limited Agents with angiogenic and wound healing activity
US8758802B2 (en) 2009-12-14 2014-06-24 University Of Massachusetts Methods of inhibiting cataracts and presbyopia
WO2012102100A1 (ja) * 2011-01-26 2012-08-02 雪印メグミルク株式会社 感覚改善剤
WO2013073968A2 (en) * 2011-09-12 2013-05-23 Industrial Research Limited Agents for modulation of cell signalling
JP2014005254A (ja) * 2012-06-26 2014-01-16 Bfsr:Kk 熱傷由来全身性炎症反応症候群の予防外用薬
EP2968239B1 (en) 2013-03-14 2019-04-24 The University of Massachusetts Methods of inhibiting cataracts and presbyopia
KR20170040648A (ko) * 2015-10-05 2017-04-13 차의과학대학교 산학협력단 당뇨병성 족부궤양의 예방 또는 치료용 약학 조성물
ES2745291T3 (es) 2015-11-13 2020-02-28 Univ Massachusetts Moléculas difuncionales que contienen PEG para su uso en la inhibición de cataratas y presbicia
KR20220023958A (ko) * 2019-02-08 2022-03-03 오클랜드 유니서비시즈 리미티드 생체 적합 물질 및 이와 관련된 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005004894A2 (en) * 2003-05-12 2005-01-20 Expressive Constructs, Inc. Methods for increasing cell and tissue viability

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2187482A1 (en) * 1995-10-13 1997-04-14 Eri Inoue Pharmaceutical composition
WO1999051634A1 (en) 1998-04-03 1999-10-14 Hunan Medical University Human gap junction protein beta-3
WO1999051738A1 (en) 1998-04-03 1999-10-14 Hunan Medical University Human gap junction protein beta-4
EP1121384A1 (en) 1998-10-15 2001-08-08 E.I. Dupont De Nemours And Company Polymers, containing a fluorocyclobutyl ring and their preparation
WO2004005883A2 (en) * 2002-07-02 2004-01-15 The Johns Hopkins University Secreted and cytoplasmic tumor endothelial markers
JP3783200B2 (ja) * 2000-08-24 2006-06-07 株式会社加美乃素本舗 血管新生剤
WO2003096981A2 (en) 2002-05-15 2003-11-27 Seul, Kyung, Hwan Method of modulating angiogenesis
US7263214B2 (en) 2002-05-15 2007-08-28 Ge Medical Systems Global Technology Company Llc Computer aided diagnosis from multiple energy images
WO2004096277A1 (ja) 2003-05-01 2004-11-11 Kyoto University 眼内血管新生疾患の予防又は治療剤
AU2005275062A1 (en) * 2004-07-14 2006-02-23 University Of Utah Research Foundation Netrin-related compositions and uses
CA2596412A1 (en) 2005-02-03 2006-12-21 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
US7897581B2 (en) 2005-02-24 2011-03-01 Massachusetts Eye & Ear Infirmary Methods and compounds for promoting vessel regression
EP1978988A4 (en) 2006-01-13 2009-11-04 Univ New York State Res Found PEPTIDE-BASED REGULATION OF GAP-JUNCTIONS
US20100004168A1 (en) 2006-06-30 2010-01-07 The Johns Hopkins University Use of Crystallin For The Modulation of Angiogenesis
KR20150072458A (ko) 2006-11-15 2015-06-29 코다 테라퓨틱스, 인크. 상처 치유를 위한 개선 방법 및 조성물
EP2104511A4 (en) 2006-12-11 2010-06-09 Univ Leland Stanford Junior ALPHA-B-CRYSTALLINE AS THERAPY AGAINST INFLAMMATION
WO2009012224A2 (en) 2007-07-13 2009-01-22 The Research Foundation Of State University Of New York Peptide-based regulation of gap junctions
WO2009029991A1 (en) * 2007-09-07 2009-03-12 Meat & Livestock Australia Limited Agents with angiogenic and wound healing activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005004894A2 (en) * 2003-05-12 2005-01-20 Expressive Constructs, Inc. Methods for increasing cell and tissue viability

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AHMED M RAFIUDDIN ET AL: "Alpha-crystallin-incorporated collagen matrices as an aid for dermal wound healing.", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH. PART B, APPLIED BIOMATERIALS 15 MAY 2004 LNKD- PUBMED:15116414, vol. 69, no. 2, 15 May 2004 (2004-05-15), pages 241 - 248, XP007914853, ISSN: 1552-4973 *
LIU B ET AL: "alphaB-crystallin inhibits glucose-induced apoptosis in vascular endothelial cells", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US LNKD- DOI:10.1016/J.BBRC.2004.06.151, vol. 321, no. 1, 13 August 2004 (2004-08-13), pages 254 - 258, XP004521426, ISSN: 0006-291X *
See also references of WO2009029991A1 *

Also Published As

Publication number Publication date
EP2407175A1 (en) 2012-01-18
US20100210531A1 (en) 2010-08-19
JP2010538020A (ja) 2010-12-09
NZ583803A (en) 2012-12-21
EP2190455A1 (en) 2010-06-02
US8404644B2 (en) 2013-03-26
WO2009029991A1 (en) 2009-03-12
EP2407175A9 (en) 2012-02-29
AU2008295449A1 (en) 2009-03-12
JP5685773B2 (ja) 2015-03-18

Similar Documents

Publication Publication Date Title
EP2190455A4 (en) AGENTS HAVING ANGIOGENIC AND WOUND HEALING ACTIVITY
DE112008002791A5 (de) Verbesserte arzneimittelbeschichtete Medizinprodukte, deren Herstellung und Verwendung
FI20075881A0 (fi) Lääketieteellinen väline ja sen käyttö
PL2038046T3 (pl) Dwuwarstwowy katalizator trójdrożny i jego zastosowanie
ATE488227T1 (de) Feste zubereitung mit alogliptin und pioglitazon
BRPI1016234A2 (pt) dispositivo aplicador para uso médico e/ou cosmético.
BRPI0912402A2 (pt) processos e kit de tratamento dos cabelos
DK2178573T3 (da) Sårplejeartikel med absorberende hylster
EP2288324A4 (en) ABSORBENT HYGIENE WITH DISPENSER
EP2352816A4 (en) HUMAN TEMPORARY CELLS
DE602007002740D1 (de) Trokar und Behandlungssystem
BRPI0822655A2 (pt) Implemento e sistema para cuidado oral
PL4066787T3 (pl) Protetyczna zastawka serca i urządzenie wprowadzające
EP2371333A4 (en) THIN CLEANER ARTICLE
ATE530553T1 (de) Zytotoxische mittel mit neuen tomamycin-derivaten und ihre therapeutische verwendung
BRPI0921919A2 (pt) dispositivos médicos, aparelhos, sistemas e métodos
BRPI0910874A2 (pt) composições e métodos para cuidado da pele
EP2331950A4 (en) NANOSTRUCTURED MICROELECTRODES AND BIODETING DEVICES INCLUDING THE SAME
DK2231091T3 (da) Absorber og absorberende engangsartikel
DE602008001981D1 (de) Stellung und therapeutische verwendung
BRPI0812264A2 (pt) Vesícula, e, preparação externa para pele
DE602007012419D1 (de) Hochfestes haftpolymergel und klebeband
DE602008002133D1 (de) Schlafbewertungsvorrichtung und Schlafbewertungsverfahren dafür
BRPI0919150A2 (pt) aplicadores de fluxo de ar e métodos de tratamento relacionados
BRPI0918789A2 (pt) variantes de beta-glicosidase tendo atividade melhorada, e uso das mesmas

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100308

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20101025

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20110606